Reply to: "Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database"

J Hepatol. 2022 Mar;76(3):744-747. doi: 10.1016/j.jhep.2021.11.020. Epub 2021 Nov 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Case-Control Studies
  • Humans
  • Intensive Care Units
  • Liver Cirrhosis / therapy
  • SARS-CoV-2